Pyroptosis: an inflammatory link between NAFLD and NASH with potential therapeutic implications
Non-alcoholic fatty liver disease (NAFLD) represents a major health problem Worldwide due to its high and rising prevalence, association with cardiovascular diseases, and risk for developing cirrhosis and hepatocellular carcinoma (HCC). NAFLD is classified in different degrees, from simple steatosis (overall 20-30% prevalence), which is considered “benign”, to steatohepatitis (NASH: 2-5% prevalence) and fibrosis.[1,2] The major risk factors of NAFLD include metabolic syndrome (i.e. obesity, diabetes, hypercholesterolemia and hypertriglyceridemia), sedentary lifestyle, genetic predispositions (e.g.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Juliane I. Beier, Jesus M. Banales Source Type: research
More News: Alcoholism | Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Cirrhosis | Diabetes | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Gastroenterology | Genetics | Heart | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Metabolic Syndrome | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Urology & Nephrology